Sign In
Buy TAK
$17.09
-0.160 (-0.93%)
At Close: Jul 31, 2026
Assetmark Inc. Buys 33,902 Shares of Takeda Pharmaceutical Co. $TAK
03:24am, Tuesday, 21'st Apr 2026
Assetmark Inc. grew its stake in Takeda Pharmaceutical Co. (NYSE: TAK) by 27.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
10:40am, Tuesday, 14'th Apr 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
My Top 4 Pharma Picks Under Rising Geopolitical Risk
12:12pm, Monday, 13'th Apr 2026
Autoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and off
Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why
01:26pm, Monday, 06'th Apr 2026
Takeda on Friday notified Denali Therapeutics regarding the termination of their collaboration agreement to co-develop DNL593, a progranulin replacement therapy for frontotemporal dementia.
Takeda Pharmaceutical Co. $TAK Shares Acquired by JPMorgan Chase & Co.
04:57am, Saturday, 04'th Apr 2026
JPMorgan Chase and Co. grew its holdings in Takeda Pharmaceutical Co. (NYSE: TAK) by 37.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 247
Takeda Pharmaceutical Company Limited (TAK) Discusses Zasocitinib Phase III Psoriasis Data and Commercial Strategy Transcript
02:45am, Sunday, 29'th Mar 2026
Takeda Pharmaceutical Company Limited (TAK) Discusses Zasocitinib Phase III Psoriasis Data and Commercial Strategy Transcript
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care.
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Takeda Pharmaceutical Company Limited (TAK) Presents at TD Cowen 46th Annual Health Care Conference Transcript
06:32pm, Wednesday, 04'th Mar 2026
Takeda Pharmaceutical Company Limited (TAK) Presents at TD Cowen 46th Annual Health Care Conference Transcript
OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food an
Takeda shares are down slightly on Friday morning after positive Phase 3 Entyvio data show strong remission rates in ulcerative colitis trial.
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can of
ABC Arbitrage SA Invests $8.37 Million in Takeda Pharmaceutical Co. $TAK
03:33am, Wednesday, 11'th Feb 2026
ABC Arbitrage SA acquired a new position in Takeda Pharmaceutical Co. (NYSE: TAK) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissi
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--FDA Accepts New Drug Application and Grants Priority Review for Takeda's Oveporexton as a Potential First-in-Class Therapy for Narcolepsy Type 1.
Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery
12:59pm, Monday, 09'th Feb 2026
AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited (NYSE: TAK).
